Showing results (381-390 of 401) with videos related to
Sort By:
Pageof 41
Cancer Research|July 22, 2010
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer riskElena Ratner, Lingeng Lu, Marta Boeke, et al.Leukemia|June 28, 2018
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomasEleni Anastasiadou, Dina Stroopinsky, Stella Alimperti, et al.Molecular Cell|August 5, 2021
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformationEsteban A Orellana, Qi Liu, Eliza Yankova, et al.Cancer Research|October 17, 2008
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer riskLena J Chin, Elena Ratner, Shuguang Leng, et al.Journal of Medicinal Chemistry|March 9, 2011
The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitisPanayiotis A Procopiou, Christopher Browning, Jennifer M Buckley, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
tRNA modifications are required for stress granule formation and melanoma metastasisRiley O Hughes, Hannah J Davis, Leona A Nease, et al.The Journal of Prevention of Alzheimer'S Disease|October 24, 2023
Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention StudyH H Feldman, S Belleville, H B Nygaard, et al.Journal of Medicinal Chemistry|September 15, 2018
Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αPanayiotis A Procopiou, Niall A Anderson, John Barrett, et al.Biorxiv : the Preprint Server for Biology|February 6, 2026
Aging-related Transcriptomic Changes with Spatial Resolution in the Human Prefrontal CortexAnupama Rai, Artemis Iatrou, Irais Valenzuela Arzeta, et al.Cell Chemical Biology|September 26, 2023
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapyHaisheng Yu, Jing Liu, Xia Bu, et al.Pageof 41